Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | YEATS4 | O95619 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7244910 | 0.97 | ALDH1A1 (0.48) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL803032 | 0.97 | ALDH1A1 (0.48) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL12339849 | 0.97 | ALDH1A1 (0.48) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL803077 | 0.94 | RIPK1 (0.48) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL673083 | 0.88 | — | — | |
| SCHEMBL10722471 | 0.88 | MEN1 (0.52) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL2676564 | 0.84 | MEN1 (0.46) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL25096322 | 0.83 | CA2 (0.53) | RIPK1MEN1KMT2AALDH1A1HDAC6 | |
| SCHEMBL24339467 | 0.82 | HTT (0.52) | RIPK1MEN1KMT2ACYP1A2HPGD | |
| SCHEMBL8485188 | 0.81 | FASN (0.44) | MEN1KMT2AALDH1A1ATMCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109415508-A | Full-size process for preparing polymer powders | 西莫-戴顿有限责任公司 | 2019-03-01 | — | — | CN | claimed |
| CN-107207693-A | Aqueous polyurethane dispersions | 塔明克公司 | 2017-09-26 | — | — | CN | claimed |
| CN-106687540-A | Low toxicity solvent system for polyamideimide and polyamide amic acid resin coating | 富士胶片亨特化学制品美国有限公司 | 2017-05-17 | — | — | CN | claimed |
| US-20240216378-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| US-20240216378-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| WO-2024130342-A1 | TRANSIENT RECEPTOR POTENTIAL VANILLOID 6 INHIBITORS | UNIQUEST PTY LIMITED (AU) | 2024-06-27 | — | — | WO | disclosed |
| US-11877464-B2 | Organic light emitting element | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11834419-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | LG CHEM, LTD. (KR) | 2023-12-05 | — | — | US | disclosed |
| US-20230364277-A1 | E-SELECTIN TARGETING AGENTS | GLYCOMIMETICS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230329106-A1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230322732-A1 | RIP1 Inhibitory Compounds and Methods for Making and Using the Same | RIGEL PHARMACEUTICALS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20070167428-A1 | Thienopyrroles as antagonists of gnrh | ASTRAZENECA AB (SE) | 2007-07-19 | — | — | US | disclosed |
| US-20070167428-A1 | Thienopyrroles as antagonists of gnrh | ASTRAZENECA AB (SE) | 2007-07-19 | — | — | US | disclosed |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | IRM LLC (BM) | 2007-06-28 | — | — | US | disclosed |
| US-20070105852-A1 | Thiophene and furan compounds | ELI LILLY AND COMPANY | 2007-05-10 | — | — | US | disclosed |
| US-20070099835-A1 | Sustained release GLP-1 receptor modulators | BRISTOL-MYERS SQUIBB COMPANY | 2007-05-03 | — | — | US | disclosed |
| US-7202381-B2 | Compounds as opioid receptor modulators | JANSSEN PHARMACEUTICA, NV (BE) | 2007-04-10 | — | — | US | disclosed |
| US-20070066573-A1 | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors | ELI LILLY AND COMPANY | 2007-03-22 | — | — | US | disclosed |
| US-20070004675-A1 | Inhibitors of VEGF receptor and HGF receptor signaling | METHYLGENE, INC. | 2007-01-04 | — | — | US | disclosed |
| US-20070004675-A1 | Inhibitors of VEGF receptor and HGF receptor signaling | METHYLGENE, INC. | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329106-A1 | ORGANIC LIGHT EMITTING ELEMENT | PPA1, PPOX, APRT | RIPK1 3328/4885MEN1 1791/4885KMT2A 3533/4885 |
| US-20070004675-A1 | Inhibitors of VEGF receptor and HGF receptor signaling | HGF, MET, FLT1 | RIPK1 1154/4885MEN1 3655/4885KMT2A 3391/4885 |
| US-11834419-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | PPOX, SETD7, CRY1 | RIPK1 2713/4885MEN1 1277/4885KMT2A 567/4885 |
| US-11877464-B2 | Organic light emitting element | CACNA2D4, CYBA, L1CAM | RIPK1 3266/4885MEN1 1889/4885KMT2A 4166/4885 |
| US-20230322732-A1 | RIP1 Inhibitory Compounds and Methods for Making and Using the Same | RIPK1, RIPK2, RIPK3 | RIPK1 1/4885MEN1 2540/4885KMT2A 3696/4885 |
| US-20070099835-A1 | Sustained release GLP-1 receptor modulators | GLP1R, GIPR, GRPR | RIPK1 1807/4885MEN1 1181/4885KMT2A 4088/4885 |
| US-20230364277-A1 | E-SELECTIN TARGETING AGENTS | SELE, SELPLG, SELP | RIPK1 3522/4885MEN1 2033/4885KMT2A 4068/4885 |
| US-20070167428-A1 | Thienopyrroles as antagonists of gnrh | GNRHR, PRLHR, TRHR | RIPK1 2183/4885MEN1 923/4885KMT2A 1902/4885 |
| US-20240216378-A1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF | EZH2, DOT1L, EED | RIPK1 2297/4885MEN1 1351/4885KMT2A 27/4885 |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | KIT, PRKCH, PRKCE | RIPK1 2266/4885MEN1 2421/4885KMT2A 646/4885 |
| US-20070105852-A1 | Thiophene and furan compounds | PSEN2, PSEN1, TPMT | RIPK1 4016/4885MEN1 3839/4885KMT2A 3101/4885 |
| US-20070066573-A1 | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors | GRIN1, GRIN3A, GRIK5 | RIPK1 793/4885MEN1 4720/4885KMT2A 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.